Trial Profile
A Randomized, Double-Blinded, Adaptive Phase 2 Study to Evaluate the Safety and Efficacy of Oral Omadacycline and Oral Nitrofurantoin in the Treatment of Female Adults With Cystitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2020
Price :
$35
*
At a glance
- Drugs Omadacycline (Primary) ; Nitrofurantoin
- Indications Cystitis; Urinary tract infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Paratek Pharmaceuticals
- 25 Oct 2020 Results presented at the IDWeek 2020
- 21 Oct 2020 According to a Paratek Pharmaceuticals media release, data are being presented at the IDWeek 2020 virtual meeting.
- 31 Oct 2019 According to a Paratek Pharmaceuticals media release, additional analyses are ongoing and the company plans on presenting data from the study at a future medical conference.